tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
US Market
Advertisement

ONO Pharmaceutical Co (OPHLF) Ratios

Compare
18 Followers

ONO Pharmaceutical Co Ratios

OPHLF's free cash flow for Q1 2026 was ¥0.71. For the 2026 fiscal year, OPHLF's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.99 3.99 3.99 2.81 4.27
Quick Ratio
2.44 3.52 3.52 2.44 3.63
Cash Ratio
1.07 1.60 1.60 0.78 1.05
Solvency Ratio
0.30 1.27 1.27 0.97 1.27
Operating Cash Flow Ratio
0.66 1.07 1.07 1.30 0.94
Short-Term Operating Cash Flow Coverage
2.59 47.90 0.00 -14.44 1.67
Net Current Asset Value
¥ 141.43B¥ 298.53B¥ 298.53B¥ 210.48B¥ 203.74B
Leverage Ratios
Debt-to-Assets Ratio
0.13 <0.01 <0.01 0.01 0.01
Debt-to-Equity Ratio
0.18 0.01 0.01 0.01 0.01
Debt-to-Capital Ratio
0.15 0.01 0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.11 0.00 0.00 >-0.01 >-0.01
Financial Leverage Ratio
1.32 1.15 1.15 1.19 1.13
Debt Service Coverage Ratio
1.90 57.66 638.79 -13.50 2.76
Interest Coverage Ratio
7.87 712.24 712.24 155.49 118.07
Debt to Market Cap
0.16 <0.01 0.00 -0.01 0.02
Interest Debt Per Share
308.21 18.94 18.94 20.65 19.49
Net Debt to EBITDA
-0.01 -0.86 -0.86 -0.52 -0.47
Profitability Margins
Gross Profit Margin
68.74%74.71%74.71%75.39%74.12%
EBIT Margin
9.86%32.62%32.62%32.30%29.31%
EBITDA Margin
16.25%36.23%36.20%37.46%35.57%
Operating Profit Margin
10.59%32.45%32.45%31.75%28.56%
Pretax Profit Margin
9.80%32.57%32.57%32.10%29.06%
Net Profit Margin
8.62%25.46%25.46%25.21%22.28%
Continuous Operations Profit Margin
8.65%25.47%25.47%25.25%22.33%
Net Income Per EBT
88.03%78.16%78.16%78.54%76.67%
EBT Per EBIT
92.53%100.39%100.39%101.11%101.77%
Return on Assets (ROA)
4.19%14.01%14.01%12.77%10.89%
Return on Equity (ROE)
5.43%16.14%16.14%15.19%12.28%
Return on Capital Employed (ROCE)
5.88%20.14%20.14%18.69%15.33%
Return on Invested Capital (ROIC)
5.01%15.66%15.70%14.87%11.13%
Return on Tangible Assets
6.66%14.94%14.94%13.86%11.94%
Earnings Yield
5.31%10.80%10.80%8.35%5.29%
Efficiency Ratios
Receivables Turnover
3.46 3.69 3.69 3.91 3.62
Payables Turnover
2.46 2.09 2.09 13.70 10.40
Inventory Turnover
2.19 2.61 2.61 2.46 2.24
Fixed Asset Turnover
4.79 4.80 4.80 4.12 3.22
Asset Turnover
0.49 0.55 0.55 0.51 0.49
Working Capital Turnover Ratio
1.76 1.89 1.89 2.04 1.96
Cash Conversion Cycle
123.38 64.17 64.17 215.35 228.92
Days of Sales Outstanding
105.47 98.80 98.80 93.37 100.79
Days of Inventory Outstanding
166.33 139.62 139.62 148.62 163.22
Days of Payables Outstanding
148.42 174.25 174.25 26.64 35.09
Operating Cycle
271.80 238.42 238.42 241.99 264.02
Cash Flow Ratios
Operating Cash Flow Per Share
180.98 230.50 230.54 326.87 124.54
Free Cash Flow Per Share
167.92 187.12 187.14 297.18 99.81
CapEx Per Share
13.06 43.39 43.39 29.69 24.73
Free Cash Flow to Operating Cash Flow
0.93 0.81 0.81 0.91 0.80
Dividend Paid and CapEx Coverage Ratio
1.95 1.91 1.91 3.61 1.55
Capital Expenditure Coverage Ratio
13.85 5.31 5.31 11.01 5.04
Operating Cash Flow Coverage Ratio
0.62 12.49 12.49 17.41 7.02
Operating Cash Flow to Sales Ratio
0.17 0.22 0.22 0.36 0.17
Free Cash Flow Yield
9.77%7.58%7.58%10.75%3.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.72 9.26 9.26 11.97 18.90
Price-to-Sales (P/S) Ratio
1.61 2.36 2.36 3.02 4.21
Price-to-Book (P/B) Ratio
1.04 1.49 1.49 1.82 2.32
Price-to-Free Cash Flow (P/FCF) Ratio
10.17 13.19 13.19 9.30 30.72
Price-to-Operating Cash Flow Ratio
9.43 10.71 10.71 8.46 24.62
Price-to-Earnings Growth (PEG) Ratio
-1.32 0.60 0.60 0.28 2.58
Price-to-Fair Value
1.04 1.49 1.49 1.82 2.32
Enterprise Value Multiple
9.92 5.64 5.65 7.54 11.37
Enterprise Value
806.19B 1.03T 1.03T 1.26T 1.46T
EV to EBITDA
9.99 5.64 5.65 7.54 11.37
EV to Sales
1.62 2.04 2.04 2.82 4.05
EV to Free Cash Flow
10.22 11.44 11.44 8.70 29.50
EV to Operating Cash Flow
9.48 9.29 9.29 7.91 23.64
Tangible Book Value Per Share
846.66 1.54K 1.54K 1.39K 1.20K
Shareholders’ Equity Per Share
1.64K 1.65K 1.65K 1.52K 1.32K
Tax and Other Ratios
Effective Tax Rate
0.12 0.22 0.22 0.21 0.23
Revenue Per Share
1.06K 1.05K 1.05K 915.80 727.88
Net Income Per Share
91.20 266.57 266.61 230.85 162.19
Tax Burden
0.88 0.78 0.78 0.79 0.77
Interest Burden
0.99 1.00 1.00 0.99 0.99
Research & Development to Revenue
0.32 0.22 0.22 0.21 0.21
SG&A to Revenue
0.00 0.15 0.15 0.20 0.21
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.98 0.86 0.86 1.11 0.59
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis